October 16, 2026 /

Webinar: Dyne Therapeutics — FORZETTO: Understanding the Phase 3 Trial of Zeleciment Rostudirsen

Parent Project Muscular Dystrophy by: Parent Project Muscular Dystrophy

Dyne Therapeutics joins PPMD for a community webinar on October 14, 2026 to present the design of ongoing FORZETTO study on z-rostudirsen (also known as DYNE-251) for individuals living with Duchenne amenable to exon 51 skipping.

Research & Clinical Trial Webinars,
Webinars

Join Our Mailing List

This field is for validation purposes and should be left unchanged.
BBB Accredited Charity logoCharity Navigator Four Star Charity logoNational Health Council Standards of Excellence Certification Program logo